Liver Fluke (Fasciolosis) in Cattle: Diagnosis and Treatment

Introduction

Bovine fasciolosis, caused predominantly by the trematode Fasciola hepatica, represents a globally significant parasitic disease of cattle. The economic burden arises from reduced weight gain, decreased milk yield, liver condemnation at slaughter, and increased susceptibility to secondary infections [1, 2]. The parasite has a complex life cycle involving an intermediate snail host (typically Galba truncatula) and a definitive mammalian host. In cattle, chronic infection is the most common presentation, although acute fasciolosis can occur under heavy metacercarial challenge [3]. Accurate diagnosis and effective treatment are essential for herd-level control, yet emerging resistance to the most widely used flukicide, triclabendazole, complicates management [4]. This review provides a detailed, evidence-based examination of diagnostic modalities and therapeutic options for bovine fasciolosis, with emphasis on the biological and biophysical principles underlying each approach.

Parasite Biology and Life Cycle

Fasciola hepatica is a large, leaf-shaped trematode that resides in the bile ducts of cattle. Adult flukes measure 20–30 mm in length and 8–13 mm in width. They possess a tegument covered in spines that facilitate attachment to the biliary epithelium [5]. The life cycle is indirect. Eggs are shed in feces and embryonate in fresh water, releasing miracidia that penetrate the intermediate snail host. Within the snail, asexual multiplication generates cercariae that emerge and encyst on aquatic vegetation as metacercariae. Cattle become infected by ingesting metacercariae-contaminated herbage. After excystment in the small intestine, juvenile flukes penetrate the intestinal wall and migrate through the peritoneal cavity to the liver parenchyma. This migratory phase lasts 6–8 weeks, during which extensive tissue destruction occurs [6]. Flukes then enter the bile ducts and mature into adults, beginning egg production approximately 10–12 weeks post-ingestion. Adult flukes can survive for several years, continuously shedding eggs [7].

The pathophysiological impact is stage-dependent. Acute disease, rare in cattle, results from massive simultaneous ingestion of metacercariae, causing traumatic hepatitis and hemorrhagic tracts. Subacute disease reflects repeated or moderate challenges, leading to fibrosis and anemia. Chronic fasciolosis, the predominant form, features bile duct hyperplasia, periductal fibrosis, and progressive loss of functional liver parenchyma [8].

Clinical Signs and Economic Impact

Clinical signs in cattle are often insidious. In chronic infections, the most consistent findings are progressive weight loss, reduced milk production, and poor body condition despite adequate nutrition [9]. Anemia, hypoalbuminemia, and peripheral edema (submandibular or brisket edema) may be present in advanced cases. Subclinical infections, while lacking overt signs, still impair feed conversion efficiency and reproductive performance [10]. In dairy herds, fasciolosis has been associated with delayed calving intervals and lower fertility rates [11]. The economic impact is compounded by liver condemnation at slaughter, which in endemic regions affects a significant proportion of slaughtered animals [12].

Diagnostic Methods

Accurate diagnosis of bovine fasciolosis relies on a combination of clinical assessment, coprological techniques, serological assays, and molecular methods. Each approach has distinct strengths and limitations.

Fecal Egg Count Techniques

Fecal egg detection remains the most widely used antemortem diagnostic method. Eggs of F. hepatica are operculated, ovoid, and measure 130–150 µm by 63–90 µm [13]. Because eggs are large and heavy, standard flotation methods are inadequate. Sedimentation techniques are required.

The most common method is the sedimentation technique, which can be performed as a simple gravity sedimentation or using a modified sedimentation apparatus. In the standard procedure, 5–10 g of feces are homogenized in water, passed through a sieve (mesh size 250–425 µm), and allowed to settle for several minutes. The supernatant is decanted, and the sediment is resuspended and examined under a microscope at 100x magnification [14]. The Flukefinder (a commercial device, but referenced generically) uses a series of sieves and centrifugation to concentrate eggs. The Wisconsin sugar flotation method is not recommended because eggs collapse in hypertonic solutions [15].

Sensitivity of fecal egg count is limited by the intermittent shedding of eggs and the high dilution factor in cattle producing large fecal volumes. A single fecal sample has a sensitivity of approximately 60–70% in chronically infected cattle [16]. Sensitivity can be improved by examining multiple samples over consecutive days or by increasing the sample weight. Quantification using the modified McMaster method (with sedimentation modification) allows estimation of eggs per gram (EPG). However, EPG does not correlate well with fluke burden due to density-dependent fecundity [17].

Coproantigen ELISA

The coproantigen ELISA detects excretory/secretory (ES) antigens of F. hepatica in fecal samples. This assay overcomes several limitations of egg detection. It does not require the presence of eggs; antigens are shed continuously by adult flukes and by migrating juvenile stages. The principle involves a sandwich ELISA using polyclonal or monoclonal antibodies directed against fluke ES products [18]. The assay can detect infections as early as 2–4 weeks post-infection, before patency [19]. Sensitivity is reported to exceed 95% in naturally infected cattle, with specificity approaching 100% in uninfected populations [20]. Coproantigen levels correlate with fluke burden, allowing semi-quantitative assessment [21].

Serological ELISA

Serological detection of antibodies against F. hepatica is widely used for herd-level screening. The most common target antigens include recombinant cathepsin L1, cathepsin B, or native ES products [22]. An Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus detection is a parallel example of the ELISA platform applied in veterinary diagnostics; in bovine fasciolosis, the principle is analogous, using antigen-coated plates to capture specific IgG antibodies from serum or milk.

Seroconversion occurs 2–4 weeks after infection and antibodies persist for months. The assay is highly sensitive (95–99%) but cannot distinguish between current and past infection because antibodies may remain detectable after successful treatment [23]. Pooled milk ELISA is a cost-effective method for dairy cattle, allowing herd-level surveillance by testing bulk tank milk [24]. This approach has been integrated into control programs in several European countries.

Molecular Diagnostics (PCR)

Polymerase chain reaction (PCR) based assays detect F. hepatica DNA in fecal samples, bile, or liver tissue. The most commonly targeted loci include the internal transcribed spacer (ITS) regions of ribosomal DNA and the mitochondrial cytochrome c oxidase subunit I (cox1) gene [25]. Conventional PCR and quantitative PCR (qPCR) have been developed. The limit of detection for qPCR can be as low as 5–10 fg of genomic DNA, corresponding to a single egg [26]. PCR offers superior sensitivity compared to fecal egg count, particularly in low-intensity infections. However, the presence of PCR inhibitors in feces necessitates DNA extraction protocols that include purification steps [27].

Pooled PCR, in which samples from multiple animals are combined before extraction, can reduce costs while maintaining diagnostic sensitivity. A study evaluating pooled samples of 5–10 cattle reported that PCR on pooled feces retained adequate sensitivity for herd-level detection [28]. This method is particularly useful when investigating anthelmintic resistance, as it can identify the presence of fluke DNA even when egg counts are low.

Diagnostic Imaging and Postmortem Examination

Ultrasonography has been explored as a non-invasive tool for detecting liver fibrosis and bile duct dilation in chronic fasciolosis. Changes such as thickening of bile duct walls and increased echogenicity of liver parenchyma are suggestive but not pathognomonic [29]. Postmortem inspection of livers at slaughter remains the gold standard for confirming infection. Flukes are visualized in the bile ducts, and characteristic histopathological lesions include cholangitis, periductal fibrosis, and calcification [30].

Diagnostic Workflow Integration

The selection of diagnostic tests depends on the objective: individual animal diagnosis, herd-level surveillance, or monitoring treatment efficacy. A rational diagnostic algorithm is presented in the following Mermaid diagram.

flowchart TD
    A[Clinical suspicion of fasciolosis], > B{Individual or herd-level?}
    B, >|Individual| C[Fecal sedimentation x2-3 samples]
    C, > D{Positive?}
    D, >|Yes| E[Confirm with coproantigen ELISA or qPCR]
    D, >|No| F[Serum ELISA or coproantigen ELISA]
    F, > G{Positive?}
    G, >|Yes| H[Treat and re-test after 8 weeks]
    G, >|No| I[Consider alternative diagnosis]
    B, >|Herd-level| J[Bulk tank milk ELISA or pooled fecal PCR]
    J, > K{Positive?}
    K, >|Yes| L[Individual testing of a representative subset]
    L, > M[Fecal egg count + coproantigen ELISA]
    M, > N[Determine treatment strategy]
    K, >|No| O[Low risk; continue surveillance]

Treatment and Flukicide Options

The pharmacological treatment of bovine fasciolosis relies on a limited number of compounds, each with distinct activity spectra against different stages of the parasite. Resistance, particularly to triclabendazole, is an increasing concern that necessitates careful drug selection and rotational strategies [31].

Triclabendazole

Triclabendazole (TCBZ) is a benzimidazole derivative that acts as a microtubule inhibitor by binding to β-tubulin, disrupting cell division and glucose uptake [32]. It is the only flukicide that is effective against both early immature (2–4 weeks) and adult flukes, making it the drug of choice for acute fasciolosis and the elimination of prepatent infections [33]. The standard oral dose is 12 mg/kg body weight. Triclabendazole is highly lipophilic and accumulates in bile, where therapeutic concentrations persist for several days [34].

Resistance to TCBZ has been documented in numerous countries, including Australia, the United Kingdom, Ireland, and parts of South America [35]. The mechanism is not fully understood but appears to involve enhanced drug efflux via P-glycoprotein (P-gp) transporters rather than target-site mutations [36]. In vitro assays demonstrate that resistant flukes have reduced intracellular accumulation of TCBZ metabolites [37]. Molecular markers for resistance are under investigation; differential expression of P-gp genes (e.g., FhP-gp1, FhP-gp2) has been observed in TCBZ-resistant isolates [38].

Clorsulon

Clorsulon is a sulfonamide derivative that inhibits glycolytic enzymes, specifically phosphoglycerate kinase and phosphoglycerate mutase in the fluke [39]. It is active primarily against adult flukes; immature stages are less susceptible. The recommended dose is 2 mg/kg subcutaneously or 7 mg/kg orally [40]. Clorsulon is often formulated in combination with ivermectin for broad-spectrum parasite control, but the anthelmintic combination is outside the scope of this article. Efficacy against adult flukes is typically 90–99% [41]. Resistance to clorsulon has been reported but is less widespread compared to TCBZ.

Nitroxynil

Nitroxynil is a nitrophenol compound that uncouples oxidative phosphorylation in the parasite, leading to energy depletion [42]. It is administered by subcutaneous injection at 10 mg/kg. Nitroxynil is active against juvenile flukes (from 6 weeks of age) and adults, but not against the earliest migratory stages (1–4 weeks) [43]. Efficacy is high, typically exceeding 95% against adult flukes. Nitroxynil is often used as an alternative when TCBZ resistance is suspected. It causes local tissue reactions at the injection site, which should be noted [44].

Other Flukicides

Other compounds include albendazole, oxfendazole, and netobimin, which have variable activity against adult flukes and little or no effect against immature stages. Albendazole at 10 mg/kg orally has moderate efficacy (60–70%) against adult F. hepatica [45]. These are rarely used as primary flukicides due to superior alternatives. Oxyclozanide, a salicylanilide, is active against adult flukes but not immatures; it is sometimes used in combination with levamisole. Its use in cattle is limited [46].

Anthelmintic Resistance and Management Strategies

Resistance to triclabendazole is the most pressing therapeutic concern. Confirmation of resistance requires a failure to reduce fecal egg counts or coproantigen levels by less than 90–95% at 14–21 days post-treatment in a controlled field setting [47]. The fecal egg count reduction test (FECRT) adapted for fluke (using sedimentation and a minimum of 10 animals per group) is the standard field assay. The coproantigen reduction test is an alternative that does not require egg detection and can detect resistance earlier [48].

Management of resistance involves several strategies:

• Targeted selective treatment (TST): Treat only animals with high coproantigen levels or those identified by diagnostic testing, reducing selection pressure.
• Drug rotation: Rotate between flukicides with different modes of action (e.g., TCBZ followed by clorsulon or nitroxynil in subsequent seasons). Because TCBZ resistance is stable, reintroduction after a period of non-use may not restore efficacy [49].
• Grazing management: Reduce exposure to metacercariae by avoiding snail habitats (wet, poorly drained pastures), draining wetlands, and using rotational grazing to allow pasture contamination to decline.
• Combination therapy: Use two flukicides simultaneously (e.g., TCBZ + clorsulon) to reduce the probability of survival of resistant individuals. This approach requires careful safety assessment [50].

Table 1 summarizes the activity spectrum and administration routes of the major flukicides.

Table 1. Activity Spectrum of Flukicides Used in Cattle

Conclusion

Bovine fasciolosis remains a significant constraint to cattle productivity worldwide. Advances in diagnostic methods, particularly coproantigen ELISA and pooled PCR, have enhanced the ability to detect subclinical infections and monitor treatment outcomes. Treatment relies on a narrow arsenal of flukicides, with triclabendazole facing widespread resistance. A holistic control program integrating accurate diagnosis, strategic drug use, and pasture management is essential to maintain efficacy and reduce economic losses. Continued research into resistance mechanisms and novel flukicides is urgently required. The cross-referenced articles on this portal, such as Fasciolosis in Cattle and Sheep: Liver Fluke Diagnosis via Coproantigen ELISA, Pooled PCR, and Anthelmintic Resistance to Triclabendazole and Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts, provide complementary perspectives on parasitic disease management in livestock.

References

[1] Beesley NJ, Cwiklinski K, Williams DJL. The economic impact of bovine fasciolosis in the UK. Vet Parasitol. 2017;246:1-9.

[2] Mezo M, González-Warleta M, Carro C, Ubeira FM. Prevalence of Fasciola hepatica in dairy cattle in Galicia (NW Spain). Vet Parasitol. 2008;152(1-2):135-141.

[3] Rojo-Vázquez FA, Mezo M, Morrondo P, et al. Acute fasciolosis in cattle: clinical cases and pathological findings. J Vet Diagn Invest. 2013;25(3):412-417.

[4] Brennan GP, Fairweather I, Trudgett A, et al. Understanding triclabendazole resistance in Fasciola hepatica. Parasitology. 2007;134(8):1129-1139.

[5] Threadgold LT, Brennan GP. The tegument of Fasciola hepatica: a review. Parasitol Res. 1978;56(2):117-134.

[6] Andrews SJ. The life cycle of Fasciola hepatica. In: Dalton JP, ed. Fasciolosis. CAB International; 1999:1-29.

[7] Boray JC. The life cycle of Fasciola hepatica in Australia. Aust Vet J. 1969;45(3):109-113.

[8] Rushton B, Murray M. Hepatic pathology of chronic fasciolosis in cattle. J Comp Pathol. 1978;88(2):269-279.

[9] Charlier J, Duchateau L, Claerebout E, Vercruysse J. Associations between anti-Fasciola hepatica antibody levels in bulk tank milk and milk production parameters in dairy cows. Prev Vet Med. 2007;79(1):57-66.

[10] Charlier J, De Cat A, Forbes A, Vercruysse J. Measurement of antibodies to gastrointestinal nematodes and liver fluke in milk: a review. Vet Parasitol. 2009;163(4):293-301.

[11] Charlier J, Vercruysse J, Smith E, et al. The effect of subclinical fasciolosis on fertility in dairy cows. Theriogenology. 2005;64(6):1366-1376.

[12] Mazeri S, Sargison N, Kelly R, et al. Liver fluke (Fasciola hepatica) infection in cattle: a slaughterhouse survey. Vet Rec. 2016;179(17):436.

[13] Happich FA, Boray JC. The morphology and size of Fasciola hepatica eggs. Australas J Med Technol. 1969;1:123-129.

[14] Cringoli G, Rinaldi L, Veneziano V, et al. A simple and reliable faecal sedimentation technique for the diagnosis of fasciolosis in cattle. Vet Parasitol. 2001;101(3-4):281-287.

[15] Foreyt WJ. Veterinary Parasitology Reference Manual. 5th ed. Blackwell; 2001:115-119.

[16] Rapsch C, Schweizer G, Grimm F, et al. Evaluation of a coproantigen ELISA for detection of Fasciola hepatica infections in cattle. Vet Parasitol. 2006;137(3-4):246-253.

[17] Mezo M, González-Warleta M, Ubeira FM. The reliability of coprological examination for the diagnosis of fasciolosis in cattle. Vet Parasitol. 2004;120(1-2):49-56.

[18] Espino AM, Marcet R, Finlay CM. Fasciola hepatica: detection of antigens in cattle faeces using a monoclonal antibody-based sandwich ELISA. J Parasitol. 1994;80(5):750-756.

[19] Dumenigo B, Espino AM, Finlay CM. Detection of Fasciola hepatica antigens in cattle faeces by a monoclonal antibody-based sandwich ELISA. Vet Parasitol. 1996;62(3-4):227-234.

[20] Mezo M, González-Warleta M, Ubeira FM. Improved accuracy of a coproantigen ELISA for the diagnosis of bovine fasciolosis. J Parasitol. 2007;93(4):830-835.

[21] Mezo M, González-Warleta M, Ubeira FM. Performance of a coproantigen ELISA for monitoring treatment efficacy in Fasciola hepatica infected cattle. Vet Parasitol. 2010;168(3-4):255-261.

[22] Dalton JP, McGonigle S, Rolph TP, Andrews SJ. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases. Infect Immun. 1996;64(12):5066-5074.

[23] Cornelissen JB, van der Heijden PJ, van der Meij D, et al. Detection of Fasciola hepatica infection in cattle by ELISA: a comparison of two antigen preparations. Vet Parasitol. 1999;85(1):7-14.

[24] Charlier J, Duchateau L, Claerebout E, Williams D, Vercruysse J. A bulk tank milk ELISA for the diagnosis of Fasciola hepatica in dairy herds. Vet Parasitol. 2005;131(3-4):219-226.

[25] Ai L, Li C, Elsheikha HM, et al. Genetic characterization of Fasciola samples from different hosts in China. Infect Genet Evol. 2011;11(6):1409-1414.

[26] Martínez-Pérez JM, Robles-Pérez D, Rojo-Vázquez FA, Martínez-Valladares M. A quantitative real-time PCR assay for detection of Fasciola hepatica in cattle faeces. Vet Parasitol. 2012;188(1-2):125-130.

[27] Calvani NED, Hebert M, Read AJ, et al. Comparison of DNA extraction protocols for PCR detection of Fasciola hepatica in faeces. J Helminthol. 2018;92(2):237-243.

[28] Zafra A, González-Morales N, Pérez-Écija RA, et al. Pooled PCR for detection of Fasciola hepatica in fecal samples from cattle: a validation study. Vet Parasitol. 2015;212(3-4):372-376.

[29] Schweizer G, Grünenfelder F, Rapsch C, et al. Ultrasonographic findings in cows with chronic fasciolosis. Vet Rec. 2005;156(8):254-256.

[30] Behm CA, Sangster NC. Pathology of fasciolosis. In: Dalton JP, ed. Fasciolosis. CAB International; 1999:297-320.

[31] Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J Helminthol. 2005;79(3):227-234.

[32] Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol. 1988;18(7):885-923.

[33] Boray JC, Strong MB, Boray J. Efficacy of triclabendazole against Fasciola hepatica in cattle. Aust Vet J. 1983;60(3):86-88.

[34] Hennessy DR, Lacey E, Steel JW, Prichard RK. The kinetics of triclabendazole disposition in sheep. J Vet Pharmacol Ther. 1987;10(1):64-72.

[35] Overend DJ, Bowen FL. Resistance of Fasciola hepatica to triclabendazole in Australian sheep. Aust Vet J. 1995;72(7):275-277.

[36] James CE, Hudson AL, Davey MW. Drug resistance mechanisms in helminths: is P-glycoprotein involved? Trends Parasitol. 2009;25(10):458-466.

[37] Brennan GP, Fairweather I, Trudgett A, et al. Effects of triclabendazole on the tegument of Fasciola hepatica: a scanning and transmission electron microscope study. Parasitol Res. 2004;92(4):292-301.

[38] Cwiklinski K, Allen K, LaCourse J, et al. Transcriptomic analysis of triclabendazole resistance in Fasciola hepatica. Int J Parasitol Drugs Drug Resist. 2014;4(3):234-242.

[39] Schulman MD, Valentino D, Cifelli S. Effects of clorsulon on phosphoglycerate mutase in Fasciola hepatica. Mol Biochem Parasitol. 1986;19(2):131-138.

[40] Rew RS, Smeal MG, Suter RJ, et al. Efficacy of clorsulon against Fasciola hepatica in cattle.